28 September, 2021
Strengthening capacity for health innovation in Africa: Launch of the H3D-F and IFPMA partnership
27 September, 2021
Intellectual Property Waiver of COVID-19 Vaccines and Treatments – An Effective Remedy?
07 September, 2021
6th GLOBAL BIOPHARMA CEO / TOP EXECS VIRTUAL PRESS BRIEFING – COVID-19 (7 September 2021)
28 June, 2021
African Public Health Leaders Virtual Session at the World Health Summit: Uganda 28-29 June 2021
26 April, 2021
Launching the IP PACT: Our approach to Intellectual Property with patient and societal benefit at its core
23 April, 2021